AI Intelligence · across all analyzed episodes
People · top 9
Companies · top 11
Topics · top 10
GLP-1 medication weight regain physiology and expectationsMicrodosing vs. standard dosing GLP-1 protocols and terminology confusionL-cell suppression and endogenous GLP-1/CCK/PYY production preservationSIBO (small intestinal bacterial overgrowth) risk in GLP-1 usersStrength training as non-negotiable component of weight loss sustainabilityObesity as multifactorial disease with genetic and epigenetic componentsLeptin resistance and metabolic adaptation after significant weight lossCircadian rhythm optimization and light exposure for metabolic healthHRT (hormone replacement therapy) for perimenopause/menopause managementLipopolysaccharide (LPS) gut dysbiosis and metabolic dysfunction
Analyzed Episodes
Jan 16, 2026
Weight Regain After GLP1s & Why It's Expected | Solo
GLP-1 medication weight regain physiology and expectationsMicrodosing vs. standard dosing GLP-1 protocols and terminology confusionL-cell suppression and endogenous GLP-1/CCK/PYY production preservation
View AnalysisJan 22, 2026
Stop Taking Supplements Blindly: The Cell Signaling Truth | Dr. Tyler Panzner
Cell signaling pathways and disease mechanismsVitamin D genetics and personalized dosing protocolsHistamine intolerance and dietary management
View AnalysisFeb 7, 2026
Weight Gain on HRT: What’s Really Causing It | Solo
Progesterone-induced insulin resistance and carbohydrate cravingsEstrogen dosing optimization and the Goldilocks curve in perimenopauseTestosterone aromatization and estrogen conversion in visceral fat
View AnalysisJan 31, 2026
6 More Hazardous Signs of Low Estrogen Your Doctor Still Misses | Solo
Low estrogen signs and symptoms in perimenopauseHormone testing protocols and timing in 30s-40sSleep disruption as estrogen deficiency marker
View Analysis